Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Rio Silver Inc. Generates Royalty Revenue and Confirms Additional Upcoming Share Issuance from Magma Silver
-
Canada Carbon Announces Appointment of New Chief Financial Officer and Extension of MOU with Irondequoit
-
RenX Enterprises Corp. Beats Revenue Guidance, Delivering $8.2 Million in Post-Acquisition Revenue While Completing Full Platform Buildout and Retiring $11.9 Million in Legacy Debt
-
DEEP SEA MINERALS CORP. ANNOUNCES MARKETING ENGAGEMENT
-
Trevi Therapeutics to Participate in Upcoming Events
-
Watsco Declares $3.30 Quarterly Dividend
-
Avicanna Reports Full Year 2025 Audited Financial Statements
-
MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference
-
Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset
-
Dyne Therapeutics Announces Participation at 2026 Academy of Managed Care Pharmacy (AMCP) Conference to Begin Shaping Access in US for Potential Neuromuscular Medicines
-
Anterix and Texas-New Mexico Power Agreement Bolsters Grid Resiliency with Proven 900 MHz Private Wireless Platform
-
Crane NXT Completes Acquisition of Antares Vision
-
Annual General Meeting of Orrön Energy AB
-
NewcelX Announces Pricing of $1.35 Million Equity Financing at 30% Premium Pricing
-
Pizza Hut UK Asks the Nation to Say “I Do” to Free Pizza!
-
MiniLuxe Announces Follow-On Investment of up to US$1.75M from Flow Capital
-
CrownTV Powers Digital Signage Experience at Victoria’s Secret Fifth Avenue Flagship
-
A Kaleidoscope Inspires the Foundation for Sarcoidosis “See Sarcoidosis” Global Campaign for Sarcoidosis Awareness Month
-
Ocugen Announces Early Completion of Dosing in Phase 2/3 Pivotal Confirmatory Trial of OCU410ST for Stargardt Disease
-
TDG Expands Recently Discovered ‘4300 Zone’ VMS Lens Below Former Hidden Creek Mine at Anyox Project
-
Charlie’s Holdings (OTCQB: CHUC) Reports 169% Growth to $20.9 Million Revenue, $4.5 Million Net Income, and Removal of "Going Concern" Opinion
-
Ocular Therapeutix™ to Present Additional SOL-1 Data and Analyses at Upcoming Scientific Conferences in April
-
Pasithea Therapeutics Announces Grant of Fast Track Designation by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) Causing Significant Morbidity
-
Bunzl Canada Celebrates EcoVadis Gold Medal for Sustainability Leadership
-
CLEAN Announces Premier American Uranium as a Silver Sponsor of the 1st Annual Nuclear in New Mexico Conference
-
Glasswing Ventures Fuels Portfolio Acceleration with Addition of 14 AI Leaders to Exclusive Advisory Councils
-
This Easter Long Weekend, Choose Safety, Drive Sober
-
Lightbridge Receives Notice of Allowance on New U.S. Patent for its Metallic Fuel Assemblies for CANDU Reactors
-
SRI Management Expands Memory Care Offering at Harper’s Station Gainesville
-
BioXcel Therapeutics Announces Food & Drug Administration Acceptance of Supplemental New Drug Application for Use of IGALMI® in the At-Home Setting
-
Coder Secures $90M Series C Led by KKR to Advance Secure Enterprise AI Development
-
Presenting on Emerging Growth Conference 91 Day 2 on April 2; Register to live stream
-
Tiziana Announces Data Showing Nasal Anti-CD3 Improves Cognition Associated with Aging
-
NewGen Filed 2025 Annual Report on Form 20-F
-
Apollomics Inc. Announces $2.0 Million Bridge Financing
-
B2Gold Announces Renewal of Normal Course Issuer Bid
-
Axsome Therapeutics Acquires Selective PDE10A Inhibitor Balipodect for the Treatment of Schizophrenia and Other Neuropsychiatric Conditions
-
Eldorado Gold Reminds Shareholders to Vote FOR the Share Issuance Resolution and Foran Mining Reminds Securityholders to Vote FOR the Arrangement Resolution
-
Charlie’s Holdings (OTCQB: CHUC) Reports 169% Growth to $20.9 Million Revenue, $4.5 Million Net Income, and Removal of "Going Concern" Opinion
-
BioXcel Therapeutics Announces Food & Drug Administration Acceptance of Supplemental New Drug Application for Use of IGALMI® in the At-Home Setting
-
Brookfield Renewable to Host First Quarter 2026 Results Conference Call
-
FitLife Brands Announces Fourth Quarter and Full-Year 2025 Results
-
Tilray Brands Delivers Record Q3 Fiscal 2026 Results; Net Revenue Increases to $207 Million with 11% Organic Growth and Gross Profit Expands to $55 Million, Increasing 6% Year-Over-Year
-
Green Thumb Industries Announces Amendment to Brand Transactions with RYTHM, Inc.
-
Brookfield Infrastructure to Host First Quarter 2026 Results Conference Call
-
Macerich Schedules First Quarter 2026 Earnings Release and Conference Call
-
RYTHM, Inc. Announces Amendments to License Agreements with Green Thumb Industries
-
Soleo Health Selected as an Authorized Specialty Pharmacy of QIVIGY® For Primary Humoral Immunodeficiency (PI) Treatment
-
Rapport Therapeutics to Present New Phase 2 Treatment Follow-Up Data for RAP-219 in Focal Onset Seizures at the 2026 American Academy of Neurology Annual Meeting
-
TIFIN Give Works With Canterbury Consulting to Expand Strategic Philanthropic Planning Capabilities
